CYRX Cryoport, Inc.

$15.02 +3.16%

Healthcare · Pharmaceutical Preparations

Cryoport, Inc. (CYRX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $757 million. Shares last traded at $15.02, 10.2% below their 52-week high. Over the past year the stock is up 122.5%. CYRX trades at a price-to-earnings ratio of 9.67, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 44.4%, above the peer median of -0.1%. Revenue grew 12.4% year over year.

Market Cap

$757M

Shares Out

50.4M

EPS (TTM)

$2.93

P/E Ratio

5.13

P/S Ratio

4.30

P/B Ratio

1.53

Dividend / Share

—

Dividend Yield

—

52-Week High

$16.72

52-Week Low

$6.32

Volume

21,439

Avg Vol (3m)

38,155.905

Performance

+4.60%

+15.27%

+80.96%

+62.20%

YTD

+57.11%

+122.52%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

58.66

SMA (50)

$12.83

SMA (200)

$10.15

Price vs SMA50

+17.09%

Price vs SMA200

+47.91%

ATR (14)

$0.73

Financials

Revenue

$176M

Net Income

$78M

Gross Margin

47.1%

Operating Margin

-20.9%

Net Margin

44.4%

Return on Equity

15.8%

Return on Assets

10.3%

Current Ratio

2.09

Debt / Equity

0.00

Revenue Growth (YoY)

+12.4%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.25	2026-05-05
FY 2025	$1.40	2026-03-05
Q3 2025	$1.68	2025-11-06
Q2 2025	$1.78	2025-08-12
Q1 2026	$-0.28	2026-05-05
FY 2025	$-2.49	2026-03-05

Full earnings history →

Pharmaceutical Preparations peers

CYRX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

9.67 / 16.82 med

-43% discount

P/S vs peers

4.30 / 3.54 med

+21% premium

Net margin vs peers

44.4% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.